Evaluation of Psychological Status in Pregnant Women Complaining of Hypertension With Pregnancy

NCT ID: NCT03503383

Last Updated: 2018-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-01

Study Completion Date

2018-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a case controlled study comparing mental health status and some psychological impacts between two groups of patients first group is pregnant women without any other medical disorder during pregnancy,the second group is pregnant women complaining of hypertension with pregnancy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension With Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Controlled group

pregnant women without any medical disorders during pregnancy

Patient Health Questionnaire-9

Intervention Type BEHAVIORAL

PHQ-9 for assessing and monitoring depression severity

Generalized Anxiety Disorder Scale (GAD-7)

Intervention Type BEHAVIORAL

to diagnose generalized anxiety disorder, the GAD-7 also proved to have good sensitivity and specificity as a screener for panic, social anxiety, and post-traumatic stress disorder

Diseased group

Patients complaining of hypertension with pregnancy

Patient Health Questionnaire-9

Intervention Type BEHAVIORAL

PHQ-9 for assessing and monitoring depression severity

Generalized Anxiety Disorder Scale (GAD-7)

Intervention Type BEHAVIORAL

to diagnose generalized anxiety disorder, the GAD-7 also proved to have good sensitivity and specificity as a screener for panic, social anxiety, and post-traumatic stress disorder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient Health Questionnaire-9

PHQ-9 for assessing and monitoring depression severity

Intervention Type BEHAVIORAL

Generalized Anxiety Disorder Scale (GAD-7)

to diagnose generalized anxiety disorder, the GAD-7 also proved to have good sensitivity and specificity as a screener for panic, social anxiety, and post-traumatic stress disorder

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PHQ-9 depression scale GAD-7

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant women
* Hypertensive pregnant women for diseased group
* Normal pregnancy with no medical disorders associated in controlled group
* singleton pregnancy
* spontaneous pregnancy
* patients who are not divorced or not widow

Exclusion Criteria

* non-pregnant women
* any other associated medical disorder with pregnancy rather than Hypertension
* any known psychological or mental disorder prior to pregnancy
* non spontaneous pregnancy as those whom conceived by IVF
* Twin or more pregnancy
* patients who are divorced or widow
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zagazig University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mena Malak Saleeb Abdalla

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mena M Abdalla, MSc

Role: PRINCIPAL_INVESTIGATOR

Zagazig University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Minya Health Insurance Hospital

Minya, , Egypt

Site Status RECRUITING

Zagazig University Hospitals

Zagazig, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mena M Abdalla, MSc

Role: CONTACT

+201010494104

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mena M Abdalla, MSc

Role: primary

+20101049414

Mena M Abdalla, MSc

Role: primary

+201010494104

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MAbdalla1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.